Published in Medical Verdicts and Law Weekly, January 18th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Regeneron Pharmaceuticals.
Report 1: Bayer HealthCare (BAY) and Regeneron Pharmaceuticals, Inc., (REGN) announced that the companies have entered into a collaboration agreement for the global development, and commercialization outside the U.S., of the VEGF Trap for the treatment of eye disease by local administration (VEGF Trap-Eye).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly